Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform

World News: . []

Trovagene Initiates Study to LINK  Response to Immunotherapy in Melanoma LINK  Using its Precision Cancer Monitoring PlatformStudy LINK  is to deliver a urinary LINK  biopsy-based solution to provide LINK  and more accurate information fo r measu...

More news and information about Trovagene, Inc.

Published By:

PR Newswire: 13:10 GMT Wednesday 8th July 2015

Published: .

Search for other references to "trovagene" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us